Myrobalan Therapeutics, a biotechnology company developing novel oral small-molecule therapies to repair damage and restore ...

Investigative compounds increase oligodendrocyte maturation in vitro and in vivo Enhanced remyelination observed in mouse model of demyelination Data presented in poster session at 40th Congress ...

BPM31510, combined with Vitamin K and standard chemoradiation, is being tested in a single-arm Phase 2b trial across four U.S. sites, with a total target enrollment of 50 patients.

Health sciences researchers and students gathered at WVU's Erickson Alumni Center on Monday to celebrate their work and what it means for the state. It was the second day of the WVU Van Liere and West ...

An article published by Harvard Medical School states that as we age, some areas of our brain, like the hippocampus, shrink in size, and the myelin sheath that surrounds and protects nerve fibers ...

BETHESDA, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of ...

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ...

By Sunday night, we'd disintegrated into sweat-soaked shells of our former selves – exhausted, sore, and horrified at how much crud accumulates when you're busy raising humans. We cracked open a ...

Her sister is supermodel Kate Moss, 50, who was poster girl for 'heroin chic' in the 1990s due ... As well as telling the ...

Thomas VanCott compares his son Jake's experience with autism to life on a tightrope. Upset the delicate balance and Jake, 18 ...

Ask Skye Siddoway's family and they'll describe her as a bright and bubbly, free-spirited person who loves to be outside. A 17-year-old student at Farmington High School, Siddoway is a star athlete.

DAYBREAK was a Phase 3, multi-center, long-term open-label extension study to evaluate the safety and efficacy of Zeposia (ozanimod) administered orally to patients with relapsing forms of multiple ...